VivoSim Labs, Inc. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-21: Form DEF 14A; Period of report 2026-09-30; Description DEF 14A; Document d143745ddef14a.htm.
- 2025-11-03: Form DEF 14A; Period of report 2025-12-16; Description DEF 14A; Document vivs-20251103.htm.
- 2024-10-07: Form DEF 14A; Period of report 2024-10-04; Description DEF 14A; Document onvo-20241004.htm.
- 2023-09-13: Form DEF 14A; Period of report 2023-10-31; Description DEF 14A; Document onvo-20230913.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-21 | DEF 14A | 2026-09-30 | DEF 14A | d143745ddef14a.htm |
| 2025-11-03 | DEF 14A | 2025-12-16 | DEF 14A | vivs-20251103.htm |
| 2024-10-07 | DEF 14A | 2024-10-04 | DEF 14A | onvo-20241004.htm |
| 2023-09-13 | DEF 14A | 2023-10-31 | DEF 14A | onvo-20230913.htm |
| 2022-07-26 | DEF 14A | 2022-09-07 | DEF 14A | onvo-def14a_20220907.htm |
| 2021-08-05 | DEF 14A | 2021-09-14 | DEF 14A | onvo-def14a_20210914.htm |
| 2020-08-06 | DEF 14A | 2020-09-15 | DEF 14A | onvo-def14a_20200915.htm |
| 2019-07-26 | DEF 14A | 2019-09-05 | DEF 14A | onvo-def14a_20190905.htm |
| 2018-06-15 | DEF 14A | 2018-07-26 | DEF 14A | onvo-def14a_20180726.htm |
| 2017-07-14 | DEF 14A | 2017-08-24 | DEF 14A | d418617ddef14a.htm |
| 2016-07-08 | DEF 14A | 2016-08-17 | DEF 14A | d276699ddef14a.htm |
| 2015-07-10 | DEF 14A | 2015-08-20 | DEF 14A | d934130ddef14a.htm |
| 2014-07-11 | DEF 14A | 2014-08-20 | DEF 14A | d741319ddef14a.htm |
| 2013-07-12 | DEF 14A | 2013-08-21 | DEF 14A | d566344ddef14a.htm |
| 2012-09-17 | DEF 14A | 2012-10-17 | DEFINITIVE PROXY STATEMENT | d409023ddef14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |